UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Corrigendum: Role of yes‐associated protein in interleukin‐13 induced nasal remodeling of chronic rhinosinusitis with nasal polyps

Allergy (Copenhagen), 2022-02, Vol.77 (2), p.713-716

2022

Volltextzugriff (PDF)

Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis

Allergy (Copenhagen), 2020-01, Vol.75 (1), p.54-62

Bieber, Thomas

2020

Volltextzugriff (PDF)

Therapeutic Effect of Curcumin on Dermatitis Induced by Acetone in Female Rats

Kufa Journal For Veterinary Medical Sciences, 2023-12, Vol.14 (2), p.1-8

2023

Volltextzugriff (PDF)

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation

Allergy (Copenhagen), 2020-05, Vol.75 (5), p.1188-1204

2020

Volltextzugriff (PDF)

Epithelial cell‐expressed type II IL‐4 receptor mediates eosinophilic esophagitis

Allergy (Copenhagen), 2023-02, Vol.78 (2), p.464-476

2023

Volltextzugriff (PDF)

Identification of serum interleukin‐13 and interleukin‐13 receptor subunit expressions: Rheumatoid arthritis–associated interstitial lung disease

International journal of rheumatic diseases, 2021-04, Vol.24 (4), p.591-598

2021

Volltextzugriff (PDF)

Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

Journal of the American Academy of Dermatology, 2023-04, Vol.88 (4), p.816-823

2023

Volltextzugriff (PDF)

The IL‐13/periostin/IL‐24 pathway causes epidermal barrier dysfunction in allergic skin inflammation

Allergy (Copenhagen), 2018-09, Vol.73 (9), p.1881-1891

2018

Volltextzugriff (PDF)

IL‐4/IL‐13 pathway in nasal type 2 inflammation: The central role and targeted therapy

Eye & ENT research (Online), 2024-06, Vol.1 (1), p.39-48

2024

Volltextzugriff (PDF)

sPLA2GIB Promotes PGD2 and IL‐13 Production in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps

The Laryngoscope, 2024-03, Vol.134 (3), p.1107-1117

2024

Volltextzugriff (PDF)

Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized placebo‐controlled phase 3 trials

Allergy (Copenhagen), 2022-04, Vol.77 (4), p.1231-1244

2022

Volltextzugriff (PDF)

IL‐13 signature in severe adult asthmatics with airway neutrophilia: A new endotype to treat

Allergy (Copenhagen), 2021-07, Vol.76 (7), p.1964-1966

2021

Volltextzugriff (PDF)

Injury, repair, inflammation and metaplasia in the stomach

The Journal of physiology, 2018-09, Vol.596 (17), p.3861-3867

2018

Volltextzugriff (PDF)

IL‐13: An essential cDC2s partner to maintain skin homeostasis

Allergy (Copenhagen), 2022-09, Vol.77 (9), p.2869-2871

2022

Volltextzugriff (PDF)

Role of IL‐13Rα2 in modulating IL‐13‐induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa

Allergy (Copenhagen), 2018-08, Vol.73 (8), p.1673-1685

2018

Volltextzugriff (PDF)

Increased circulating T follicular helper 13 subset correlates with high IgE levels in pediatric allergic asthma

European journal of immunology, 2022-12, Vol.52 (12), p.2010-2012

2022

Volltextzugriff (PDF)

IL‐13 in dermal type‐2 dendritic cell specialization: From function to therapeutic targeting

European journal of immunology, 2022-07, Vol.52 (7), p.1047-1057

2022

Volltextzugriff (PDF)

Peripheral airways type 2 inflammation, neutrophilia and microbial dysbiosis in severe asthma

Allergy (Copenhagen), 2021-07, Vol.76 (7), p.2070-2078

2021

Volltextzugriff (PDF)

Age and early maternal smoking contribute to epithelial cell IL‐13 responsiveness in a pediatric asthma population

Allergy (Copenhagen), 2019-12, Vol.74 (12), p.2485-2487

2019

Volltextzugriff (PDF)

IL‐4/IL‐13‐producing ILC2s are required for timely control of intestinal helminth infection in mice

European journal of immunology, 2022-12, Vol.52 (12), p.1925-1933

2022

Volltextzugriff (PDF)

IL‐4 and IL‐13 are not involved in IL‐31‐induced itch‐associated scratching behaviour in mice

Experimental dermatology, 2024-06, Vol.33 (6), p.e15115-n/a

2024

Volltextzugriff (PDF)

The stimulation of TH2 cells results in increased IL‐5 and IL‐13 production via the H4 receptor

Allergy (Copenhagen), 2024-08, Vol.79 (8), p.2186-2196

2024

Volltextzugriff (PDF)

Hypochlorous acid is antipruritic and anti‐inflammatory in a mouse model of atopic dermatitis

Clinical and experimental allergy, 2018-01, Vol.48 (1), p.78-88

2018

Volltextzugriff (PDF)

Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis—A pooled analysis of trial data

Pediatric dermatology, 2022-03, Vol.39 (2), p.187-196

2022

Volltextzugriff (PDF)

Lipopolysaccharide induces steroid‐resistant exacerbations in a mouse model of allergic airway disease collectively through IL‐13 and pulmonary macrophage activation

Clinical and experimental allergy, 2020-01, Vol.50 (1), p.82-94

2020

Volltextzugriff (PDF)

1 – 25 von 271

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(261)
Mit Volltextzugriff
(267)

Publikationsform

Artikel
(266)
Buchkapitel
(5)

Sprache

Englisch
(271)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Corrigendum: Role of yes‐associated protein in interleukin‐13 induced nasal remodeling of chronic rhinosinusitis with nasal polyps

Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis

Therapeutic Effect of Curcumin on Dermatitis Induced by Acetone in Female Rats

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation

Epithelial cell‐expressed type II IL‐4 receptor mediates eosinophilic esophagitis

Identification of serum interleukin‐13 and interleukin‐13 receptor subunit expressions: Rheumatoid arthritis–associated interstitial lung disease

Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

The IL‐13/periostin/IL‐24 pathway causes epidermal barrier dysfunction in allergic skin inflammation

IL‐4/IL‐13 pathway in nasal type 2 inflammation: The central role and targeted therapy

sPLA2GIB Promotes PGD2 and IL‐13 Production in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps

Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized placebo‐controlled phase 3 trials

IL‐13 signature in severe adult asthmatics with airway neutrophilia: A new endotype to treat

Injury, repair, inflammation and metaplasia in the stomach

IL‐13: An essential cDC2s partner to maintain skin homeostasis

Role of IL‐13Rα2 in modulating IL‐13‐induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa

Increased circulating T follicular helper 13 subset correlates with high IgE levels in pediatric allergic asthma

IL‐13 in dermal type‐2 dendritic cell specialization: From function to therapeutic targeting

Peripheral airways type 2 inflammation, neutrophilia and microbial dysbiosis in severe asthma

Age and early maternal smoking contribute to epithelial cell IL‐13 responsiveness in a pediatric asthma population

IL‐4/IL‐13‐producing ILC2s are required for timely control of intestinal helminth infection in mice

IL‐4 and IL‐13 are not involved in IL‐31‐induced itch‐associated scratching behaviour in mice

The stimulation of TH2 cells results in increased IL‐5 and IL‐13 production via the H4 receptor

Hypochlorous acid is antipruritic and anti‐inflammatory in a mouse model of atopic dermatitis

Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis—A pooled analysis of trial data

Lipopolysaccharide induces steroid‐resistant exacerbations in a mouse model of allergic airway disease collectively through IL‐13 and pulmonary macrophage activation

Suchergebnisse filtern